Chondrosarcoma: biology, genetics, and epigenetics

F1000Res. 2018 Nov 20:7:F1000 Faculty Rev-1826. doi: 10.12688/f1000research.15953.1. eCollection 2018.


Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets.

Keywords: chondrosarcoma; epigenetics biology; genetics.

Publication types

  • Review

MeSH terms

  • Bone Neoplasms* / genetics
  • Bone Neoplasms* / pathology
  • Bone Neoplasms* / therapy
  • Chondrosarcoma* / genetics
  • Chondrosarcoma* / pathology
  • Chondrosarcoma* / therapy
  • Epigenesis, Genetic
  • Humans
  • Prognosis
  • Therapeutics / trends

Grants and funding

The author(s) declared that no grants were involved in supporting this work.